Table 2. Correlation between Ln5-γ2 expression levels and clinicopathological parameters of with squamous cell carcinoma.
|
Ln5-γ2
|
|||
|---|---|---|---|
| High expression (score 3 and 4) (n=25) | Low expression (score 1 and 2) (n=28) | P-value | |
| Age (in years) | >0.9a | ||
| ⩽60 | 3 | 3 | |
| >60 | 22 | 25 | |
| Sex | 0.4a | ||
| Male | 9 | 14 | |
| Female | 16 | 14 | |
| Differentiation | 0.8b | ||
| Well | 22 | 24 | |
| Moderate | 3 | 3 | |
| Poor | 0 | 1 | |
| Thickness (mm) | 0.1c | ||
| Mean | 8.1 | 6.9 | |
| Range | 2–17 | 1–24 | |
| Grade | 0.3b | ||
| 0 | 0 | 0 | |
| I | 14 | 9 | |
| II | 6 | 15 | |
| III | 5 | 4 | |
| IV | 0 | 0 | |
| Lymph node metastasis | 0.1a | ||
| (+) | 6 | 2 | |
| (−) | 2 | 6 | |
n=53 (positive cases).
a
By Fisher's exact test.
b
By Mann–Whitney U-test.
c
By Student's t-test.